HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Elevated CA 19-9 levels in a patient with Mirizzi syndrome: case report.

Abstract
CA 19-9 is a marker of malignancy of the pancreas and biliary tract. We report the case of a patient who had significantly elevated serum CA 19-9 levels and imaging studies suggestive of malignancy. On laparotomy, the patient was found to have Mirizzi syndrome, an uncommon cause of biliary obstruction from an impacted gallstone. This case illustrates that elevated serum CA 19-9 levels must be interpreted cautiously in cases of biliary obstruction.
AuthorsMayra Sanchez, Hilton Gomes, Erin N Marcus
JournalSouthern medical journal (South Med J) Vol. 99 Issue 2 Pg. 160-3 (Feb 2006) ISSN: 0038-4348 [Print] United States
PMID16509554 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Biomarkers
  • CA-19-9 Antigen
Topics
  • Biomarkers (blood)
  • Biopsy, Needle
  • CA-19-9 Antigen (blood)
  • Cholangiocarcinoma (diagnosis)
  • Choledocholithiasis (blood, diagnosis, surgery)
  • Cholestasis, Extrahepatic (blood, diagnosis, etiology)
  • Diagnosis, Differential
  • Gallbladder Neoplasms (diagnosis)
  • Humans
  • Jaundice, Obstructive (complications, diagnosis, surgery)
  • Laparotomy
  • Magnetic Resonance Imaging
  • Male
  • Middle Aged
  • Syndrome
  • Tomography, X-Ray Computed

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: